Artemisinin With Risperidone for First-Episode and Drug-Naive Schizophrenia

NCT01391403 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
88
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Beijing HuiLongGuan Hospital

Collaborators